Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Simone Guadagna"'
Autor:
Dumitru Emanuel Dogaru, Serban Rosu, Dionisio Franco Barattini, Simone Guadagna, Luca Barattini, Bogdan Andor
Publikováno v:
JMIR Research Protocols, Vol 13, p e13642 (2024)
BackgroundOsteoarthritis (OA) is a disabling condition that affects more than one-third of people older than 65 years. Currently, 80% of these patients report movement limitations, 20% are unable to perform major activities of daily living, and appro
Externí odkaz:
https://doaj.org/article/4317cf1e66e74360991bd77308d0f9cb
Autor:
Diego Scheggia, Rosa Mastrogiacomo, Maddalena Mereu, Sara Sannino, Richard E. Straub, Marco Armando, Francesca Managò, Simone Guadagna, Fabrizio Piras, Fengyu Zhang, Joel E. Kleinman, Thomas M. Hyde, Sanne S. Kaalund, Maria Pontillo, Genny Orso, Carlo Caltagirone, Emiliana Borrelli, Maria A. De Luca, Stefano Vicari, Daniel R. Weinberger, Gianfranco Spalletta, Francesco Papaleo
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Patients with schizophrenia show varied response to antipsychotics. Here, the authors demonstrate in patients under antipsychotics treatment that a haplotype associated with lower dysbindin-1 expression correlated with better executive functions, pro
Externí odkaz:
https://doaj.org/article/0e5f124f37b14a83811e7cceee5dc56c
Autor:
Raffaele Serra, Nicola Ielapi, Andrea Bitonti, Stefano Candido, Salvatore Fregola, Alessandro Gallo, Antonio Loria, Lucia Muraca, Luca Raimondo, Luminița Velcean, Simone Guadagna, Luca Gallelli
Publikováno v:
Nutrients, Vol 13, Iss 3, p 999 (2021)
Chronic Venous Disease (CVD) is a common medical condition affecting up to 80% of the general population. Clinical manifestations can range from mild to more severe signs and symptoms that contribute to the impairment of the quality of life (QoL) of
Externí odkaz:
https://doaj.org/article/8b30075a38ec44998ceabd67fa65068c
Autor:
Diego Scheggia, Rosa Mastrogiacomo, Maddalena Mereu, Sara Sannino, Richard E. Straub, Marco Armando, Francesca Managò, Simone Guadagna, Fabrizio Piras, Fengyu Zhang, Joel E. Kleinman, Thomas M. Hyde, Sanne S. Kaalund, Maria Pontillo, Genny Orso, Carlo Caltagirone, Emiliana Borrelli, Maria A. De Luca, Stefano Vicari, Daniel R. Weinberger, Gianfranco Spalletta, Francesco Papaleo
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-1 (2018)
In the original version of this Article, references in the Methods section incorrectly referred to references in the Supplementary References section. The relevant references (now numbered 20, 27, 42, 47, 69–80) have been removed from the Supplemen
Externí odkaz:
https://doaj.org/article/b9def1781218440784dceee7ac28fc40
Autor:
Raffaele Serra, Luca Gallelli, Luminița Velcean, Luca Raimondo, Stefano Candido, Alessandro Gallo, Andrea Bitonti, Antonio Loria, Salvatore Fregola, Simone Guadagna, Lucia Muraca, Nicola Ielapi
Publikováno v:
Nutrients, Vol 13, Iss 999, p 999 (2021)
Nutrients
Volume 13
Issue 3
Nutrients
Volume 13
Issue 3
Chronic Venous Disease (CVD) is a common medical condition affecting up to 80% of the general population. Clinical manifestations can range from mild to more severe signs and symptoms that contribute to the impairment of the quality of life (QoL) of
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2020 (2020)
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-based Complementary and Alternative Medicine : eCAM
Background. Sleep complaints are common health issues in the general population. These conditions are associated with poorer physical and psychological activity, and they may have important social, economic, and personal consequences. In the last yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b071b32314000136aac472fc0c874d3
Autor:
Bogdan Corneliu Andor, Dionisio Franco Barattini, Dumitru Emanuel Dogaru, Simone Guadagna, Serban Rosu
BACKGROUND Osteoarthritis (OA) is one of the top five most disabling conditions and it affects more than one third of persons over 65 years of age. Currently 80% of persons affected by OA already report having some movement limitation, 20% of people
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e443cc7e8cbc8ce11adf1a8966c56500
https://doi.org/10.2196/preprints.13642
https://doi.org/10.2196/preprints.13642
Autor:
Simone Guadagna, Paul T. Francis, Shu Qing Koh, Peter T.-H. Wong, Christopher P Chen, Margaret M. Esiri, Jasinda H. Lee, Gavin S. Dawe, Mitchell K.P. Lai
Publikováno v:
Psychopharmacology. 233:591-598
The G-protein-coupled relaxin family receptors RXFP1 and RXFP3 are widely expressed in the cortex and are involved in stress responses and memory and emotional processing. However, the identification of these receptors in human cortex and their statu
Autor:
Gianfranco Spalletta, Rosa Mastrogiacomo, Emiliana Borrelli, Sanne S Kaalund, Sara Sannino, Francesca Managò, Genny Orso, Carlo Caltagirone, Fabrizio Piras, Francesco Papaleo, Diego Scheggia, Daniel R. Weinberger, Joel E. Kleinman, Fengyu Zhang, Richard E. Straub, Stefano Vicari, Maria Antonietta De Luca, Simone Guadagna, Maria Pontillo, Marco Armando, Thomas M. Hyde, Maddalena Mereu
Publikováno v:
Nature Communications
Nature Communications, Vol 9, Iss 1, Pp 1-1 (2018)
Nature Communications, Vol 9, Iss 1, Pp 1-1 (2018)
Antipsychotics are the most widely used medications for the treatment of schizophrenia spectrum disorders. While such drugs generally ameliorate positive symptoms, clinical responses are highly variable in terms of negative symptoms and cognitive imp
Autor:
Stefano Vicari, Sara Sannino, Rosa Mastrogiacomo, Emiliana Borrelli, Daniel R. Weinberger, Marco Armando, Fabrizio Piras, Genny Orso, Thomas M. Hyde, Carlo Caltagirone, Joel E. Kleinman, Fengyu Zhang, Richard E. Straub, Gianfranco Spalletta, Maria Antonietta De Luca, Maddalena Mereu, Maria Pontillo, Diego Scheggia, Francesca Managò, Francesco Papaleo, Simone Guadagna, Sanne S Kaalund
Publikováno v:
Nature communications, vol. 9, no. 1, pp. 2265
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Nature Communications
Scheggia, D; Mastrogiacomo, R; Mereu, M; Sannino, S; Straub, RE; Armando, M; et al.(2018). Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment. NATURE COMMUNICATIONS, 9. doi: 10.1038/s41467-018-04711-w. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/3w10w6s7
Nature Communications, Vol. 9, No 1 (2018) P. 2265
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Nature Communications
Scheggia, D; Mastrogiacomo, R; Mereu, M; Sannino, S; Straub, RE; Armando, M; et al.(2018). Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment. NATURE COMMUNICATIONS, 9. doi: 10.1038/s41467-018-04711-w. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/3w10w6s7
Nature Communications, Vol. 9, No 1 (2018) P. 2265
Antipsychotics are the most widely used medications for the treatment of schizophrenia spectrum disorders. While such drugs generally ameliorate positive symptoms, clinical responses are highly variable in terms of negative symptoms and cognitive imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22db0804d97530353658fae922ec5536
https://serval.unil.ch/resource/serval:BIB_0BD8D7D05BDD.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_0BD8D7D05BDD.P001/REF.pdf